Lexpos News

Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined the November 2025 reimbursement price for the following product to reflect an increase in their NHS list prices. To avoid pharmacy owners dispensing these products at a loss, DHSC has agreed to [...]

The post Retrospective reimbursement prices for November 2025 appeared first on Community Pharmacy England.

Pharmacy owners are being reminded that recent changes to speed up payment of flu vaccination provision means their end of December payment may be lower than expected, having already been paid in November. Following a change in policy, several NHS services are now being paid on the same date as the early Advance payment for [...]

The post Flu payments change: Be aware of potential cashflow implications appeared first on Community Pharmacy England.

Following the introduction of hub and spoke dispensing between different legal entities this autumn, Community Pharmacy England’s Regulations Team reminds pharmacy owners of the guidance available to help them decide whether it’s appropriate for their pharmacy business.  Among those pharmacies that are not currently using hub and spoke, around 36% are still exploring their options, and 10% haven’t considered it yet, according to our November sector poll. To support them in their considerations, the [...]

The post Hub and Spoke: What you need to know appeared first on Community Pharmacy England.

In response to a significant ongoing disruption to the supply of Adipine® XL 30mg MR tablets and Adipine® XL 60mg MR tablets, two Serious Shortage Protocol (SSP) have been issued by the Department of Health and Social Care (DHSC). SSP084 Adipine® XL 30mg MR tablets Effective today, 19 December 2025, SSP084 provides that for every one Adipine® [...]

The post Two SSPs issued for Adipine® XL 30mg MR tablets and Adipine® XL 60mg MR tablets appeared first on Community Pharmacy England.

In response to a significant ongoing disruption to the supply of Latanoprost 50micrograms/ml / Timolol 5mg/ml (Fixapost®) eye drops 0.2ml unit dose preservative free, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today 19 December 2025, SSP086 provides that for every 2.5ml bottle of Latanoprost 50micrograms/ml [...]

The post New SSP issued for Latanoprost 50micrograms/ml / Timolol 5mg/ml (Fixapost®) eye drops 0.2ml unit dose preservative free appeared first on Community Pharmacy England.